{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/275620735"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Sandoz (pronounced ???SAN-doh???), the generics arm of Swiss drug maker Novartis, announced the start of a phase-2 trial of rituximab, a biosimilar of Genentech???s Rituxan, used to treat such conditions as non-Hodgkin???s lymphoma and rheumatoid arthritis." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "drugstorenews.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/352028105"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/275620735" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/186054321"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/275620735"] } } }
